Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Hast

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
American Journal of Epidemiology|May 8, 2019
The Impact of 3 Years of Targeted Indoor Residual Spraying With Pirimiphos-Methyl on Malaria Parasite Prevalence in a High-Transmission Area of Northern ZambiaMarisa A Hast, Mike Chaponda, Mbanga Muleba, et al.
Molecular and Biochemical Parasitology|January 9, 2007
Resistance mutations at the lipid substrate binding site of Plasmodium falciparum protein farnesyltransferaseRichard T Eastman, John White, Oliver Hucke, et al.
MMWR. Morbidity and Mortality Weekly Report|May 29, 2020
Notes from the Field: Impact of a Mass Drug Administration Campaign Using a Novel Three-Drug Regimen on Lymphatic Filariasis Antigenemia - American Samoa, 2019Marisa A Hast, Aifili Tufa, Tara A Brant, et al.
Plos Pathogens|August 31, 2013
Phosphorylation of Calcineurin at a novel serine-proline rich region orchestrates hyphal growth and virulence in Aspergillus fumigatusPraveen R Juvvadi, Christopher Gehrke, Jarrod R Fortwendel, et al.
Chemistry & Biology|February 28, 2009
Structural basis for binding and selectivity of antimalarial and anticancer ethylenediamine inhibitors to protein farnesyltransferaseMichael A Hast, Steven Fletcher, Christopher G Cummings, et al.
The American Journal of Tropical Medicine and Hygiene|May 11, 2019
Risk Factors for Household Vector Abundance Using Indoor CDC Light Traps in a High Malaria Transmission Area of Northern ZambiaMarisa A Hast, Jennifer C Stevenson, Mbanga Muleba, et al.
Journal of Medicinal Chemistry|September 9, 2010
Structure-based design and synthesis of potent, ethylenediamine-based, mammalian farnesyltransferase inhibitors as anticancer agentsSteven Fletcher, Erin Pusateri Keaney, Christopher G Cummings, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
American Journal of Epidemiology|May 8, 2019
The Impact of 3 Years of Targeted Indoor Residual Spraying With Pirimiphos-Methyl on Malaria Parasite Prevalence in a High-Transmission Area of Northern ZambiaMarisa A Hast, Mike Chaponda, Mbanga Muleba, et al.
Molecular and Biochemical Parasitology|January 9, 2007
Resistance mutations at the lipid substrate binding site of Plasmodium falciparum protein farnesyltransferaseRichard T Eastman, John White, Oliver Hucke, et al.
MMWR. Morbidity and Mortality Weekly Report|May 29, 2020
Notes from the Field: Impact of a Mass Drug Administration Campaign Using a Novel Three-Drug Regimen on Lymphatic Filariasis Antigenemia - American Samoa, 2019Marisa A Hast, Aifili Tufa, Tara A Brant, et al.
Plos Pathogens|August 31, 2013
Phosphorylation of Calcineurin at a novel serine-proline rich region orchestrates hyphal growth and virulence in Aspergillus fumigatusPraveen R Juvvadi, Christopher Gehrke, Jarrod R Fortwendel, et al.
Chemistry & Biology|February 28, 2009
Structural basis for binding and selectivity of antimalarial and anticancer ethylenediamine inhibitors to protein farnesyltransferaseMichael A Hast, Steven Fletcher, Christopher G Cummings, et al.
The American Journal of Tropical Medicine and Hygiene|May 11, 2019
Risk Factors for Household Vector Abundance Using Indoor CDC Light Traps in a High Malaria Transmission Area of Northern ZambiaMarisa A Hast, Jennifer C Stevenson, Mbanga Muleba, et al.
Journal of Medicinal Chemistry|September 9, 2010
Structure-based design and synthesis of potent, ethylenediamine-based, mammalian farnesyltransferase inhibitors as anticancer agentsSteven Fletcher, Erin Pusateri Keaney, Christopher G Cummings, et al.
Pageof 4